articleTop 1% cited
Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
Atherosclerosis · 2009 · Vol. 205(2) · pp. 385–390
Majd A.I. Mirza(Uppsala University Hospital)Anders Larsson(Uppsala University Hospital)Lars Lind(Uppsala University Hospital)Tobias E. Larsson✉(Uppsala University Hospital)
Parathyroid Disorders and TreatmentsFibroblast Growth Factor ResearchMagnesium in Health and DiseaseArterial stiffnessMedicineInternal medicineFibroblast growth factor 23Kidney diseaseCardiologyRenal functionEndothelial dysfunctionRisk factorEndocrinology
MeSH terms
Fibroblast Growth Factor-23AgedEndothelium, VascularFemaleFibroblast Growth FactorsGlomerular Filtration RateHumansKidney Failure, ChronicMaleSurveys and QuestionnairesRandom AllocationReference ValuesRisk FactorsSex FactorsVasodilation
Citations
387
FWCI
13.95
field-weighted impact
References
25
Percentile
99%
vs. same field & year
Citations per year
Cited by
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
Kidney International · 2011 · 1,223 citations
References
FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis
Journal of Bone and Mineral Research · 2004 · 1,848 citations
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Journal of the American Society of Nephrology · 2004 · 2,666 citations
Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality
Nephrology Dialysis Transplantation · 2003 · 1,844 citations
Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease
Hypertension · 2001 · 1,406 citations
Prediction of Coronary Heart Disease Using Risk Factor Categories
Circulation · 1998 · 9,571 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.